FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Shivaani Kummar

Research Profile

Disorders

Chemicals & Drugs

Procedures

Concepts & Ideas

Devices

Drug Delivery Systems

Co-author Network

Publications

TOP 3
Sook Ryun Park; Thomas Pfister; Richard Piekarz; Giovanna Speranza; Seth M Steinberg; Jane B Trepel; Lihua Wang; John J Wright; Sylvia Alarcon; Jerry Collins; James H Doroshow; Robert Kinders; Min-Jung Lee; Shivaani Kummar
A multi-histology trial of fostamatinib in patients with advanced colorectal, non-small cell lung, head and neck, thyroid, and renal cell carcinomas, and pheochromocytomas.
Shivaani Kummar; Eva Majerova; Larry Rubinstein; Deborah Allen; Larry Anderson; James H Doroshow; Pamela Harris; Kimberly Hill; Yvonne Horneffer; S Percy Ivy; Jerry M Collins
First-in-human phase 0 trial of oral 5-iodo-2-pyrimidinone-2'-deoxyribose in patients with advanced malignancies.
Shivaani Kummar; James H Doroshow
Molecular targets in cancer therapy.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Shivaani Kummar (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Sook Ryun Park; Thomas Pfister; Richard Piekarz; Giovanna Speranza; Seth M Steinberg; Jane B Trepel; Lihua Wang; John J Wright; Sylvia Alarcon; Jerry Collins; James H Doroshow; Robert Kinders; Min-Jung Lee; Shivaani Kummar
A multi-histology trial of fostamatinib in patients with advanced colorectal, non-small cell lung, head and neck, thyroid, and renal cell carcinomas, and pheochromocytomas.
Cancer chemotherapy and pharmacology 2013;71(4):981-90.
2013: Shivaani Kummar; Eva Majerova; Larry Rubinstein; Deborah Allen; Larry Anderson; James H Doroshow; Pamela Harris; Kimberly Hill; Yvonne Horneffer; S Percy Ivy; Jerry M Collins
First-in-human phase 0 trial of oral 5-iodo-2-pyrimidinone-2'-deoxyribose in patients with advanced malignancies.
Clinical cancer research : an official journal of the American Association for Cancer Research 2013;19(7):1852-7.
2013: Shivaani Kummar; James H Doroshow
Molecular targets in cancer therapy.
Expert review of anticancer therapy 2013;13(3):267-9.
2013: Sook Ryun Park; Myrtle Davis; James H Doroshow; Shivaani Kummar
Safety and feasibility of targeted agent combinations in solid tumours.
Nature reviews. Clinical oncology 2013;10(3):154-68.
2012: Khanh Do; James H Doroshow; Shivaani Kummar
Antiangiogenic approaches for the treatment of advanced synovial sarcomas.
Current opinion in oncology 2012;24(4):425-30.
2012: Arun Rajan; Shawn Spencer; Eva Szabo; Sukyung Woo; Mary Ann Yancey; Martin Gutierrez; Jiuping Ji; Ronan J Kelly; Shivaani Kummar; Baskar Mannargudi; Corey A Carter; William Douglas Figg; Giuseppe Giaccone
A phase I combination study of olaparib with cisplatin and gemcitabine in adults with solid tumors.
Clinical cancer research : an official journal of the American Association for Cancer Research 2012;18(8):2344-51.
2012: Cody J Peer; Emily D Richardson; Tristan Sissung; Sarah M Troutman; David Venzon; BRIGITTE WIDEMANN; Sukyung Woo; Robert Yarchoan; William Dahut; Bevin C English; Joel Federspiel; Erin R Gardner; Giuseppe Giaccone; Lokesh Jain; Aerang Kim; C Tyler Kirkland; Elise Kohn; Shivaani Kummar; William D Figg
Sorafenib is an inhibitor of UGT1A1 but is metabolized by UGT1A9: implications of genetic variants on pharmacokinetics and hyperbilirubinemia.
Clinical cancer research : an official journal of the American Association for Cancer Research 2012;18(7):2099-107.
2012: Shivaani Kummar; Heinz-Josef Lenz; Robert Morgan; Edward M Newman; Ralph E Parchment; Shannon L Puhalla; Larry Rubinstein; Joseph E Tomaszewski; Lihua Wang; Yiping Zhang; Deborah Allen; Chandra P Belani; Jan H Beumer; Alice Chen; David R Gandara; Jiuping Ji; Brian Kiesel; Robert Kinders; James Doroshow
A phase I study of veliparib in combination with metronomic cyclophosphamide in adults with refractory solid tumors and lymphomas.
Clinical cancer research : an official journal of the American Association for Cancer Research 2012;18(6):1726-34.
2012: Giovanna Speranza; John M Strong; Yunkai Yu; Liang Cao; Jerry Collins; James H Doroshow; Martin E Gutierrez; Shivaani Kummar; Anthony J Murgo; Robert J Parker; Alice Chen
Phase I study of the synthetic triterpenoid, 2-cyano-3, 12-dioxoolean-1, 9-dien-28-oic acid (CDDO), in advanced solid tumors.
Cancer chemotherapy and pharmacology 2012;69(2):431-8.
2012: Thomas D Pfister; Yves Pommier; Howard Stotler; Joseph E Tomaszewski; Yiping Zhang; Suzanne D Borgel; John Carter; Raymond Divelbiss; Yvonne A Evrard; Melinda G Hollingshead; Jiuping Ji; Sonny A Khin; Robert Kinders; Shivaani Kummar; Ralph E Parchment; James H Doroshow
Development and validation of an immunoassay for quantification of topoisomerase I in solid tumor tissues.
PloS one 2012;7(12):e50494.
2012: Shivaani Kummar; Ralph E Parchment; Joseph E Tomaszewski; Alice Chen; Jay Ji; Robert Kinders; James H Doroshow
Advances in using PARP inhibitors to treat cancer.
BMC medicine 2012;10():25.
2011: Arun Rajan; Michael Shnaidman; Jane B Trepel; Wadih M Zein; Sylvia V Alarcon; Nicoletta Brega; Sonja Crandon; William D Figg; Martin Gutierrez; Brett E Houk; Lokesh Jain; Ronan J Kelly; Yeong Sang Kim; Shivaani Kummar; Baskar Mannargudi; Giuseppe Giaccone
A phase I study of PF-04929113 (SNX-5422), an orally bioavailable heat shock protein 90 inhibitor, in patients with refractory solid tumor malignancies and lymphomas.
Clinical cancer research : an official journal of the American Association for Cancer Research 2011;17(21):6831-9.
2011: Shivaani Kummar; Giovanni Melillo; Anthony J Murgo; Ralph E Parchment; Yves Pommier; Joel M Reid; Larry Rubinstein; Giovanna Speranza; Howard Stotler; Joseph E Tomaszewski; Lihua Wang; Marcie Weil; Yiping Zhang; Matthew Ames; William Bonner; John Carter; Alice Chen; Melinda G Hollingshead; Jiuping Ji; Lee Jia; Robert Kinders; James H Doroshow
Phase I study of PARP inhibitor ABT-888 in combination with topotecan in adults with refractory solid tumors and lymphomas.
Cancer research 2011;71(17):5626-34.
2011: Athanassios Argiris; Zhong Chen; Theresa Cooley-Zgela; Austin G Duffy; Minyoung Jang; Vishnu R Kannabiran; Seungwon W Kim; Shivaani Kummar; Mukesh K Nyati; Susmita G Ramanand; Susan F Rudy; Nicole L Simone; Nanette Suksta; Aarif Ahsan; Yoshio Arai; John J Wright; Xinping Yang; Carter Van Waes
Early tumor progression associated with enhanced EGFR signaling with bortezomib, cetuximab, and radiotherapy for head and neck cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2011;17(17):5755-64.
2011: Lokesh Jain; Elise C Kohn; Shivaani Kummar; Diane R Mould; Jürgen Venitz; Sukyung Woo; Robert Yarchoan; William L Dahut; Erin R Gardner; Giuseppe Giaccone; William D Figg
Population pharmacokinetic analysis of sorafenib in patients with solid tumours.
British journal of clinical pharmacology 2011;72(2):294-305.
2011: Shivaani Kummar; Shwu-Huey Liu; Mark O'Rourke; Michal Rose; Joe Stephenson; Tahmun Su; Robert Tilton; Scott Wadler; Wayne Brenckman; Yung-Chi Cheng; M Sitki Copur; Zaoli Jiang; Edward Chu
A phase I study of the chinese herbal medicine PHY906 as a modulator of irinotecan-based chemotherapy in patients with advanced colorectal cancer.
Clinical colorectal cancer 2011;10(2):85-96.
2011: Shivaani Kummar; Martin E Gutierrez; Alice Chen; Ismail B Turkbey; Deborah Allen; Yvonne R Horneffer; Lamin Juwara; Liang Cao; Yunkai Yu; Yeong Sang Kim; Jane Trepel; Helen Chen; Peter Choyke; Giovanni Melillo; Anthony J Murgo; Jerry Collins; James H Doroshow
Phase I trial of vandetanib and bevacizumab evaluating the VEGF and EGF signal transduction pathways in adults with solid tumours and lymphomas.
European journal of cancer (Oxford, England : 1990) 2011;47(7):997-1005.
2011: Shivaani Kummar; Martin E Gutierrez; Barry J Maurer; Charles Patrick Reynolds; Min Kang; Hardeep Singh; Sonja Crandon; Anthony J Murgo; James H Doroshow
Phase I trial of fenretinide lym-x-sorb oral powder in adults with solid tumors and lymphomas.
Anticancer research 2011;31(3):961-6.
2011: Shivaani Kummar; James H Doroshow
Phase 0 trials: expediting the development of chemoprevention agents.
Cancer prevention research (Philadelphia, Pa.) 2011;4(3):288-92.
2011: Ronan J Kelly; Arun Rajan; Jeremy Force; Ariel Lopez-Chavez; Corrine Keen; Liang Cao; Yunkai Yu; Peter Choyke; Baris Turkbey; Mark Raffeld; Liqiang Xi; Seth M Steinberg; John J Wright; Shivaani Kummar; Martin Gutierrez; Giuseppe Giaccone
Evaluation of KRAS mutations, angiogenic biomarkers, and DCE-MRI in patients with advanced non-small-cell lung cancer receiving sorafenib.
Clinical cancer research : an official journal of the American Association for Cancer Research 2011;17(5):1190-9.
2011: Jiuping Ji; Robert Kinders; Shivaani Kummar; Ralph E Parchment; Larry Rubinstein; Joseph E Tomaszewski; Yiping Zhang; James H Doroshow
Modeling pharmacodynamic response to the poly(ADP-Ribose) polymerase inhibitor ABT-888 in human peripheral blood mononuclear cells.
PloS one 2011;6(10):e26152.
2011: Shivaani Kummar
Foreword. Poly(ADP-ribose) polymerase inhibitors in clinical development.
Current problems in cancer 2011;35(1):6.
2010: Shivaani Kummar; Helen X Chen; John Wright; Susan Holbeck; Myrtle Davis Millin; Joseph Tomaszewski; James Zweibel; Jerry Collins; James H Doroshow
Utilizing targeted cancer therapeutic agents in combination: novel approaches and urgent requirements.
Nature reviews. Drug discovery 2010;9(11):843-56.
2010: Suresh S Ramalingam; Shivaani Kummar; John Sarantopoulos; Stephen Shibata; Patricia M LoRusso; Mara Yerk; Julianne Holleran; Yan Lin; Jan H Beumer; R Donald Harvey; S Percy Ivy; Chandra P Belani; Merrill J Egorin
Phase I study of vorinostat in patients with advanced solid tumors and hepatic dysfunction: a National Cancer Institute Organ Dysfunction Working Group study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(29):4507-12.
2010: Giovanna Speranza; James H Doroshow; Shivaani Kummar
Adenocarcinoma of the small bowel: changes in the landscape?
Current opinion in oncology 2010;22(4):387-93.
2010: Larry V Rubinstein; Seth M Steinberg; Shivaani Kummar; Robert Kinders; Ralph E Parchment; Anthony J Murgo; Joseph E Tomaszewski; James H Doroshow
The statistics of phase 0 trials.
Statistics in medicine 2010;29(10):1072-6.
2010: Carla Kurkjian; Shivaani Kummar; David Stewart; Kenneth Waxman; Albert Lam; Siddarth Shah; James Paparello; Warren A Katz; Robert L Barkin
Topics in clinical pharmacology: renal, gastrointestinal, and pain management.
Disease-a-month : DM 2010;56(4):187-250.
2010: Shivaani Kummar
Evaluation of multiple targeted agents as potential therapies for hepatocellular carcinoma (HCC). Foreword.
Current problems in cancer 2010;34(2):130.
2010: Lihua H Wang; Thomas D Pfister; Ralph E Parchment; Shivaani Kummar; Larry Rubinstein; Yvonne A Evrard; Martin E Gutierrez; Anthony J Murgo; Joseph E Tomaszewski; James Doroshow; Robert Kinders
Monitoring drug-induced gammaH2AX as a pharmacodynamic biomarker in individual circulating tumor cells.
Clinical cancer research : an official journal of the American Association for Cancer Research 2010;16(3):1073-84.
2010: Lokesh Jain; Tristan Sissung; Romano Danesi; Elise C Kohn; William L Dahut; Shivaani Kummar; David Venzon; David J Liewehr; Bevin C English; Caitlin E Baum; Robert Yarchoan; Giuseppe Giaccone; Jürgen Venitz; Douglas K Price; William D Figg
Hypertension and hand-foot skin reactions related to VEGFR2 genotype and improved clinical outcome following bevacizumab and sorafenib.
Journal of experimental & clinical cancer research : CR 2010;29():95.
2010: Shivaani Kummar; Martin E Gutierrez; Erin R Gardner; Xiaohong Chen; William D Figg; Maria Zajac-Kaye; Min Chen; Seth M Steinberg; Christine A Muir; Mary Ann Yancey; Yvonne R Horneffer; Lamin Juwara; Giovanni Melillo; S Percy Ivy; Maria Merino; Len Neckers; Patricia S Steeg; BA Conley; Giuseppe Giaccone; James Doroshow; Anthony J Murgo
Phase I trial of 17-dimethylaminoethylamino-17-demethoxygeldanamycin (17-DMAG), a heat shock protein inhibitor, administered twice weekly in patients with advanced malignancies.
European journal of cancer (Oxford, England : 1990) 2010;46(2):340-7.
2010: Shivaani Kummar; Martin E Gutierrez; Erin R Gardner; William D Figg; Giovanni Melillo; Janet Dancey; Edward A Sausville; BA Conley; Anthony J Murgo; James Doroshow
A phase I trial of UCN-01 and prednisone in patients with refractory solid tumors and lymphomas.
Cancer chemotherapy and pharmacology 2010;65(2):383-9.
2010: Austin Duffy; Shivaani Kummar
Metastatic pancreatic adenocarcinoma: current standards, future directions.
American journal of therapeutics 2010;17(1):79-85.
2009: Austin Duffy; Shivaani Kummar
Targeting mitogen-activated protein kinase kinase (MEK) in solid tumors.
Targeted oncology 2009;4(4):267-73.
2009: James H Doroshow; Shivaani Kummar
Role of Phase 0 trials in drug development.
Future medicinal chemistry 2009;1(8):1375-80.
2009: Sherry X Yang; Shivaani Kummar; Seth M Steinberg; Anthony J Murgo; Martin Gutierrez; Larry Rubinstein; Dat Nguyen; Gurmeet Kaur; Alice P Chen; Vincent L Giranda; Joseph E Tomaszewski; James H Doroshow
Immunohistochemical detection of poly(ADP-ribose) polymerase inhibition by ABT-888 in patients with refractory solid tumors and lymphomas.
Cancer biology & therapy 2009;8(21):2004-9.
2009: Carla Kurkjian; Shivaani Kummar
Advances in the treatment of metastatic colorectal cancer.
American journal of therapeutics 2009;16(5):412-20.
2009: Shivaani Kummar; Robert Kinders; Martin E Gutierrez; Larry Rubinstein; Ralph E Parchment; Lawrence R Phillips; Jiuping Ji; Anne Monks; Jennifer A Low; Alice Chen; Anthony J Murgo; Jerry Collins; Seth M Steinberg; Helen Eliopoulos; Vincent L Giranda; Gary Gordon; Lee Helman; Robert Wiltrout; Joseph E Tomaszewski; James Doroshow
Phase 0 clinical trial of the poly (ADP-ribose) polymerase inhibitor ABT-888 in patients with advanced malignancies.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(16):2705-11.
2009: Martin E Gutierrez; Shivaani Kummar; Giuseppe Giaccone
Next generation oncology drug development: opportunities and challenges.
Nature reviews. Clinical oncology 2009;6(5):259-65.
2009: Shivaani Kummar
Targeted therapy for advanced non-small cell lung cancers: historical perspective, current practices, and future development. Foreword.
Current problems in cancer 2009;33(2):72.
2009: Shivaani Kummar; James Doroshow; Joseph E Tomaszewski; A Hilary Calvert; Marinus Lobbezoo; Giuseppe Giaccone
Phase 0 clinical trials: recommendations from the Task Force on Methodology for the Development of Innovative Cancer Therapies.
European journal of cancer (Oxford, England : 1990) 2009;45(5):741-6.
2009: Shivaani Kummar
Multiple Myeloma. Foreword.
Current problems in cancer 2009;33(1):6.
2008: Min-Jung Lee; Yeong Sang Kim; Shivaani Kummar; Giuseppe Giaccone; Jane Trepel
Histone deacetylase inhibitors in cancer therapy.
Current opinion in oncology 2008;20(6):639-49.
2008: Carla Kurkjian; Shivaani Kummar; Anthony J Murgo
DNA methylation: its role in cancer development and therapy.
Current problems in cancer 2008;32(5):187-235.
2008: Carla Kurkjian; Shivaani Kummar; Anthony J Murgo
The observation that changes in DNA methylation potentially play a role in neoplastic transformation has existed for nearly 30 years. Foreword.
Current problems in cancer 2008;32(5):185-6.
2008: Carla Kurkjian; Anthony J Murgo; Shivaani Kummar
Treatment of recurrent metastatic colon cancer in the age of modern adjuvant therapy.
Clinical colorectal cancer 2008;7(5):321-4.
2008: Tsoching Chen; Min-Jung Lee; Yeong Sang Kim; Sunmin Lee; Shivaani Kummar; Martin Gutierrez; Stephen M Hewitt; Jane Trepel; Ira Levin
Pharmacodynamic assessment of histone deacetylase inhibitors: infrared vibrational spectroscopic imaging of protein acetylation.
Analytical chemistry 2008;80(16):6390-6.
2008: Shivaani Kummar
The mammalian target of rapamycin (mTOR). Foreword.
Current problems in cancer 2008;32(4):160.
2008: Anthony J Murgo; Shivaani Kummar; Larry Rubinstein; Martin Gutierrez; Jerry Collins; Robert Kinders; Ralph E Parchment; Jiuping Ji; Seth M Steinberg; Sherry X Yang; Melinda G Hollingshead; Alice Chen; Lee Helman; Robert Wiltrout; Joseph E Tomaszewski; James Doroshow
Designing phase 0 cancer clinical trials.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(12):3675-82.
2008: Shivaani Kummar; Larry Rubinstein; Robert Kinders; Ralph E Parchment; Martin E Gutierrez; Anthony J Murgo; Jay Ji; Barbara Mroczkowski; Oxana Pickeral; Mel Simpson; Melinda G Hollingshead; Sherry X Yang; Lee Helman; Robert Wiltrout; Jerry Collins; Joseph E Tomaszewski; James Doroshow
Phase 0 clinical trials: conceptions and misconceptions.
Cancer journal (Sudbury, Mass.) 2008;14(3):133-7.
2008: Erin A Donovan; Shivaani Kummar
Role of insulin-like growth factor-1R system in colorectal carcinogenesis.
Critical reviews in oncology/hematology 2008;66(2):91-8.
2007: Robert Kinders; Ralph E Parchment; Jay Ji; Shivaani Kummar; Anthony J Murgo; Martin Gutierrez; Jerry Collins; Larry Rubinstein; Oxana Pickeral; Seth M Steinberg; Sherry Yang; Melinda G Hollingshead; Alice Chen; Lee Helman; Robert Wiltrout; Mel Simpson; Joseph E Tomaszewski; James Doroshow
Phase 0 clinical trials in cancer drug development: from FDA guidance to clinical practice.
Molecular interventions 2007;7(6):325-34.
2007: Xiaohong Chen; Erin R Gardner; Martin Gutierrez; Shivaani Kummar; William D Figg
Determination of 17-dimethylaminoethylamino-17-demethoxygeldanamycin in human plasma by liquid chromatography with mass-spectrometric detection.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 2007;858(1-2):302-6.
2007: Shivaani Kummar; Martin Gutierrez; Erin R Gardner; Erin Donovan; Kyunghwa Hwang; Eun Joo Chung; Min-Jung Lee; Kim Maynard; Mikhail Kalnitskiy; Alice Chen; Giovanni Melillo; Qin C Ryan; BA Conley; William D Figg; Jane Trepel; James Zwiebel; James Doroshow; Anthony J Murgo
Phase I trial of MS-275, a histone deacetylase inhibitor, administered weekly in refractory solid tumors and lymphoid malignancies.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(18 Pt 1):5411-7.
2007: Shivaani Kummar; Robert Kinders; Larry Rubinstein; Ralph E Parchment; Anthony J Murgo; Jerry Collins; Oxana Pickeral; Jennifer Low; Seth M Steinberg; Martin Gutierrez; Sherry Yang; Lee Helman; Robert Wiltrout; Joseph E Tomaszewski; James Doroshow
Compressing drug development timelines in oncology using phase '0' trials.
Nature reviews. Cancer 2007;7(2):131-9.
2006: BA Conley; John J Wright; Shivaani Kummar
Targeting epigenetic abnormalities with histone deacetylase inhibitors.
Cancer 2006;107(4):832-40.
2006: Shivaani Kummar; Martin Gutierrez; James Doroshow; Anthony J Murgo
Drug development in oncology: classical cytotoxics and molecularly targeted agents.
British journal of clinical pharmacology 2006;62(1):15-26.
2006: Kyunghwa Hwang; Charity D Scripture; Martin Gutierrez; Shivaani Kummar; William D Figg; Alex Sparreboom
Determination of the heat shock protein 90 inhibitor 17-dimethylaminoethylamino-17-demethoxygeldanamycin in plasma by liquid chromatography-electrospray mass spectrometry.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 2006;830(1):35-40.
2006: Erin A Donovan; Shivaani Kummar
Targeting VEGF in cancer therapy.
Current problems in cancer 2006;30(1):7-32.
2005: Deirdre O'Mahony; Shivaani Kummar; Martin E Gutierrez
Non-small-cell lung cancer vaccine therapy: a concise review.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(35):9022-8.
2005: Claude Sportès; Nicole J McCarthy; Frances T Hakim; Seth M Steinberg; David J Liewehr; David Weng; Shivaani Kummar; Juan Gea-Banacloche; Catherine K Chow; Robert M Dean; Kathleen Castro; Donna Marchigiani; Michael Bishop; Daniel H Fowler; Ronald E Gress
Establishing a platform for immunotherapy: clinical outcome and study of immune reconstitution after high-dose chemotherapy with progenitor cell support in breast cancer patients.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2005;11(6):472-83.
2005: John R Murren; Manuel Modiano; Shivaani Kummar; Caroline Clairmont; Merrill J Egorin; Edward Chu; Mario Sznol
A phase I and pharmacokinetic study of VNP40101M, a new alkylating agent, in patients with advanced or metastatic cancer.
Investigational new drugs 2005;23(2):123-35.
2005: Vanita Noronha; Nelofar Q Shafi; J Antonio Obando; Shivaani Kummar
Primary non-Hodgkin's lymphoma of the liver.
Critical reviews in oncology/hematology 2005;53(3):199-207.
2004: Shivaani Kummar; Nelofar Q Shafi
False elevations in prostate-specific antigen levels affecting patient management.
Clinical advances in hematology & oncology : H&O 2004;2(9):599-601; discussion 602.
2004: Erole M Hobdy; Nelofar Q Shafi; Shivaani Kummar
Prostate cancer metastasis to supraclavicular lymph node.
Clinical advances in hematology & oncology : H&O 2004;2(4):223-4; discussion 224.
2003: Shivaani Kummar; Nelofar Q Shafi
Metastatic hepatocellular carcinoma.
Clinical oncology (Royal College of Radiologists (Great Britain)) 2003;15(5):288-94.
2003: Erole M Hobdy; Thomas E Ciesielski; Shivaani Kummar
Unusual sites of colorectal cancer metastasis.
Clinical colorectal cancer 2003;3(1):54-7.
2003: Michael P Farrell; Shivaani Kummar
Phase I/IIA randomized study of PHY906, a novel herbal agent, as a modulator of chemotherapy in patients with advanced colorectal cancer.
Clinical colorectal cancer 2003;2(4):253-6.
2002: Shivaani Kummar; Thomas E Ciesielski; Miklos C Fogarasi
Management of small bowel adenocarcinoma.
Oncology (Williston Park, N.Y.) 2002;16(10):1364-9; discussion 1370, 1372-3.
2002: Shivaani Kummar; Miklos C Fogarasi; A Canova; A Mota; Thomas E Ciesielski
Cytokeratin 7 and 20 staining for the diagnosis of lung and colorectal adenocarcinoma.
British journal of cancer 2002;86(12):1884-7.
2001: Shivaani Kummar; Thomas E Ciesielski
Cytokeratin staining for primary and metastatic colorectal cancer.
Clinical colorectal cancer 2001;1(3):187-8.
2001: Miklos C Fogarasi; R S Zelkowitz; S A Messana; J A Arrighi; John P Seibyl; Shivaani Kummar
Positron emission tomography for the evaluation of patients with colorectal cancer.
Clinical colorectal cancer 2001;1(2):117-20.
2001: Shivaani Kummar; A Ishii; H K Yang; D J Venzon; S J Kim; Ronald E Gress
Modulation of graft-versus-tumor effects in a murine allogeneic bone marrow transplantation model by tumor-derived transforming growth factor-betaI.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2001;7(1):25-30.